主页 > 医药生命 >
【bio-news】密苏里州同意干细胞研究
Missouri OKs Stem Cell Research
By Eli Kintisch
ScienceNOW Daily News
8 November 2006
Missouri voters have narrowly approved a measure sanctioning embryonic stem cell research in the state. The amendment to the state constitution received 51% of yesterday's vote after supporters waged a $30 million advertising campaign that included celebrities such as Michael J. Fox. Elsewhere, three governors who had backed stem cell research in their states won re-election, while one of the biggest congressional opponents of their use--U.S. Senator Rick Santorum (R-PA)--was trounced.
"I'm very proud of Missouri," says Steve Teitelbaum, a Washington University bone pathologist who has campaigned on the grassroots level around the state for years on the issue. He predicts that the small but potent research community of universities and biotech companies centered in St. Louis and Kansas City will benefit from passage of the amendment--which prevents lawmakers from barring work on embryonic stem cells while criminalizing cloning with the goal of reproduction--as will patients. "It's going to energize the biotech community," he says.
Opponents took heart from having come so close after September polls showed them trailing by 20 percentage points. "The amendment was sold to the public on the basis of cures. It's going to be interesting to see what happens if those are not forthcoming," said Barbara Quigley, executive director of the Missouri-based pro-life Center for Bioethics and Culture, which joined the opposition.
The attention to Amendment 2 appears to have helped Missouri Democrat Claire McCaskill win a Senate seat over the incumbent Republican, Jim Talent. Her campaign made national headlines with an advertisement featuring Fox attacking her opponent for opposition to the research.
The issue had national resonance as well. Governor Jim Doyle of Wisconsin, a Democrat, also campaigned hard on his support of stem cells in a successful bid for reelection. Likewise, governors Arnold Schwarzenegger of California and Rod Blagojevich of Illinois kept their jobs as well.
In congressional races, Maryland Republican Michael Steele, who opposed research using embryos, lost to Democrat Ben Cardin. In an open seat in Pennsylvania, Democrat Patrick Murphy defeated Michael Fitzpatrick, a Republican who had opposed the research. At the same time, Democrat Chris Bell pushed for stem cell research but lost in a bid for Texas governorship and physician Victoria Wulsin was trailing her Republican opponent for an Ohio House seat in a campaign in which she had emphasized her support for stem cell research.
Teitelbaum says the new Democrat majority in the U.S. House could bolster efforts to expand federal funding of embryonic stem cell research beyond the limits that President George W. Bush laid down in 2001. But Bush vetoed such a bill last summer, and the conservative leanings of many of the new Democrats raise a cautionary note to those who would like to see a new push in the 110th Congress that convenes in January.
Related sites 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 Missouri OKs Stem Cell Research
密苏里州支持干细胞研究
Missouri voters have narrowly approved a measure sanctioning embryonic stem cell research in the state. 密苏里州投票以微弱优势通过了批准在该州进行胚胎干细胞研究的法案。The amendment to the state constitution received 51% of yesterday's vote after supporters waged a $30 million advertising campaign that included celebrities such as Michael J. Fox.这项州宪法修正案在支持者耗费近3千万美元广告费用的宣传攻势下，在昨日投票中获得了51％的支持率，参加这项活动的包括各界名流，诸如Michael J. Fox等。Elsewhere, three governors who had backed stem cell research in their states won re-election, 除此之外，三位支持干细胞研究的州长分别在各自辖区获选连任。while one of the biggest congressional opponents of their use--U.S. Senator Rick Santorum (R-PA)--was trounced. 而在国会中以强烈反对胚胎干细胞研究著称的议员Rick Santorum 在竞选中落败。
"I'm very proud of Missouri,"“我以密苏里州为荣，” says Steve Teitelbaum, a Washington University bone pathologist who has campaigned on the grassroots level around the state for years on the issue. Steve Teitelbaum 说，他是华盛顿大学的骨病理学家，多年来活跃在基层，致力于推动胚胎干细胞研究在该州的合法化。He predicts that the small but potent research community of universities and biotech companies centered in St. Louis and Kansas City will benefit from passage of the amendment--which prevents lawmakers from barring work on embryonic stem cells while criminalizing cloning with the goal of reproduction--as will patients. "It's going to energize the biotech community," he says.他预言以圣路易斯和康萨斯为中心的规模较小但技术力量强大的大学研究团体和生物技术公司将从修正案获得通过事件中受益，而且修正案的通过可以防止立法者以违法为由阻碍胚胎干细胞研究，杜绝以生殖为目的的非法克隆活动。患者也将从中获益。他说“这将为整个生物技术学界注入活力。”
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-06-02 17:11
医学,生命科学网